1 - 10 out of 12Page size: 10
  1. 2024

  2. Rotational and near-infrared spectra of PbF: Characterization of the coupled X1 Π1/2 2 and X2 Π3/2 2 states

    Jackson, S., Kim, L., Biekert, A., Nguyen, A., Mawhorter, R. J., Sears, T. J., Skripnikov, L. V., Baturo, V. V., Petrov, A. N. & Grabow, J-U., 2024, In: Physical Review A. 110, 4

    Research output: Contribution to journal › Article › peer-review

  3. 2022

  4. Broadband intermodal fiber interferometer for sensor application: fundamentals and simulator

    Petrov, A. V., Bisyarin, M. A. & Kotov, O. I., 1 Aug 2022, In: Applied Optics. 61, 22, p. 6544-6552 9 p.

    Research output: Contribution to journal › Article › peer-review

  5. 2020

  6. Intermodal fiber interferometer with frequency scanning laser for sensor application

    Petrov, A. V., Chapalo, I. E., Bisyarin, M. A. & Kotov, O. I., 20 Nov 2020, In: Applied Optics. 59, 33, p. 10422-10431 10 p.

    Research output: Contribution to journal › Article › peer-review

  7. 2019

  8. Influence of Microvascular Disease on Cardiovascular Events in Type 2 Diabetes

    EMPA-REG OUTCOME Investigators, 4 Jun 2019, In: Journal of the American College of Cardiology. 73, 21, p. 2780-2782 3 p.

    Research output: Contribution to journal › Letter › peer-review

  9. 2018

  10. Investigation of Topological and Kinetic Characteristics of Catalytic Glass Fiber Materials

    Petrov, A. N., Vitkovskaya, R. F., Petrov, S. V. & Dregulo, A. M., 1 Sep 2018, In: Fibre chemistry. 50, 3, p. 252-257 6 p.

    Research output: Contribution to journal › Article › peer-review

  11. Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease

    EMPA-REG OUTCOME Investigators, 9 Jan 2018, In: Circulation. 137, 2, p. 119-129 11 p.

    Research output: Contribution to journal › Article › peer-review

  12. 2017

  13. Low-temperature equilibriums in solutions of isocyanide-phosphine complexes of palladium(II) chloride

    Kinzhalov, M. A., Buldakov, A. V., Petrov, A. V., Mahmudov, K. T., Ivanov, A. Y. & Suslonov, V. V., 1 Nov 2017, In: Russian Journal of General Chemistry. 87, 11, p. 2605-2611 7 p.

    Research output: Contribution to journal › Article › peer-review

  14. Empagliflozin and Cerebrovascular Events in Patients With Type 2 Diabetes Mellitus at High Cardiovascular Risk

    EMPA-REG OUTCOME Investigators, May 2017, In: Stroke. 48, 5, p. 1218-+ 31 p.

    Research output: Contribution to journal › Article › peer-review

  15. Comparison of E. Coli strains producing human interleukin-36 receptor antagonist (IL-36RA) with coexpression of E. coli methionine aminopeptidase

    Kolobov, A. A., Kondratyeva, E. V., Kudling, T. V., Karasev, M. M., Kalinin, R. S., Khizhina, A. A., Protasov, E. A., Nimiritsky, P. P., Stefanov, V. E. & Petrov, A. V., 2017, In: Russian Journal of Biopharmaceuticals. 9, 4, p. 20-26 7 p.

    Research output: Contribution to journal › Article › peer-review

  16. 2016

  17. Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME (R) trial

    EMPA-REG OUTCOME Investigators, 14 May 2016, In: European Heart Journal. 37, 19, p. 1526-1534 9 p.

    Research output: Contribution to journal › Article › peer-review

Previous 1 2 Next

ID: 16277164